CADTH conducted a Health Technology Review on remdesivir — an antiviral drug currently being used to treat COVID-19. Remdesivir was approved in Canada on July 27, 2020 to treat adults and adolescents with severe symptoms of COVID-19 who have pneumonia and require extra oxygen. Five randomized controlled trials were identified and included in the review. […]
CADTH conducted a Rapid Response Report to search for clinical evidence or evidence-based guidelines regarding the use of respiratory personal protective equipment designed specifically for female presenting individuals during COVID-19. However, no clinical evidence or evidence-based guidelines were identified. References that did not meet the inclusion criteria, but may still be of interest, were included […]
To find effective treatment for COVID-19, researchers have started studying older drugs approved for other infections or diseases. One recent drug of interest is ivermectin, a drug typically used to treat patients with parasitic infections (e.g., roundworm). This report looks at the evidence regarding ivermectin to treat patients with COVID-19 infections. While some lab studies […]
This newsletter article provides an overview of saliva-based testing in the context of the COVID-19 pandemic. The article briefly explores the different types of COVID-19 tests, the potential advantages of using saliva samples for testing, the clinical evidence, and the current practice in Canada. Link to Report Saliva-Based Testing as an Alternative to Traditional COVID-19 […]
A properly fitted respirator device (e.g., N95 masks) is an important piece of personal protective equipment. With the COVID-19 pandemic, there is greater interest in how well filtering respirator devices fit when a person has facial hair — like a beard, moustache, or sideburns. This report looks at the evidence regarding facial hair and respirator […]